Taken together, the entire set of studies reported in this review strengthens the role of miRNAs not only as regulators of glucose homeostasis through the specific modulation of insulin signaling components, but also as potential therapeutic targets and/or agents ameliorating insulin-resistance and other pathogenic factors contributing to T2D. Here, INS is linked to type 2 diabetes mellitus.